Temporal trends in serum concentrations of polychlorinated dioxins, furans, and PCBs among adult women living in Chapaevsk, Russia: a longitudinal study from 2000 to 2009
© Humblet et al; licensee BioMed Central Ltd. 2011
Received: 24 November 2010
Accepted: 22 June 2011
Published: 22 June 2011
The present study assessed the temporal trend in serum concentrations of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls (PCBs) among residents of a Russian town where levels of these chemicals are elevated due to prior industrial activity.
Two serum samples were collected from eight adult women (in 2000 and 2009), and analyzed with gas chromatography-high-resolution mass spectrometry.
The average total toxic equivalency (TEQ) decreased by 30% (from 36 to 25 pg/g lipid), and the average sum of PCB congeners decreased by 19% (from 291 to 211 ng/g lipid). Total TEQs decreased for seven of the eight women, and the sum of PCBs decreased for six of eight women. During this nine year period, larger decreases in serum TEQs and PCBs were found in women with greater increases in body mass index.
This study provides suggestive evidence that average serum concentrations of dioxins, furans, and PCBs are decreasing over time among residents of this town.
Polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and biphenyls (PCBs) are classes of toxic organochlorine compounds which are ubiquitous in the environment [1, 2]. They are lipophilic and persistent, and their elimination from the body can take years or even decades . Current human exposure is mostly through diet , although some populations may have continuing environmental exposures due to past or current industrial activity [5–8].
Numerous studies in the general population have reported that serum concentrations of these chemicals correlate positively with age [9, 10], but also that average population levels are declining over time . The objective of this study was to characterize temporal trends in serum concentrations of PCDD/PCDF/PCBs among reproductive age women living in Chapaevsk, Russia. Elevated levels of these compounds have been detected in serum samples from Chapaevsk residents [12, 13], as well as in environmental samples and food . For over 50 years this town was the site of chlorinated chemical production at the Middle Volga Chemical Plant , also known as SVZH. Plant activity started decreasing in 1991 , and ceased in 2003. The plant produced chemical blister agents (mustard gas and lewisite) prior to 1949, hexachlorocyclohexane (lindane) and its derivatives from 1967 to 1987, then crop protection chemicals (liquid chlorine, acids, methyl chloroform, and vinyl chloride) until its closure . Dioxins were generated as unwanted by-products of chemical manufacturing , whereas PCBs were typically used in electrical capacitors and transformers, although their specific use at SVZH is unknown. Environmental release of these chemicals most likely occurred during incineration and disposal of hazardous waste from the plant. We collected serum samples nine years apart (in 2000 and 2009) from eight non-occupationally exposed women living in Chapaevsk, and in 2009 all samples were sent for analysis of PCDD/PCDF/PCBs.
Ten healthy women were recruited in 2000 for a pilot feasibility study on early pregnancy loss, at which time a serum sample was collected and archived, and a health and lifestyle questionnaire was completed. Newly married women in Chapaevsk were invited to join, and 10 enrolled in the pilot project. To be included in the original study women needed to be married, age 20-34 years, and trying to conceive. To investigate temporal trends in PCDD/PCDF/PCB exposure, participants were re-contacted in 2009, and a second serum sample and lifestyle questionnaire was collected from eight of the ten women (of the two others, one had left Chapaevsk, and one declined to participate).
The research protocol was approved by the Human Studies Institutional Review Boards of the Chapaevsk Medical Association, UMass Medical School, and Harvard School of Public Health. All participants gave their consent before participating in each of the two assessments.
Measurement of dioxin, furan, and PCB serum concentrations
Samples were stored at -20 degrees C until analysis. All 16 serum samples (10-15 ml each) were analyzed in 2009 using isotope dilution gas chromatography-high-resolution mass spectrometry (GC-HRMS-ID) at the Laboratory of Analytical Toxicology of the Severtsov Institute of Ecology and Evolution in Moscow, Russia. The list of dioxin-like congeners (called dioxins in this manuscript) included 7 PCDDs, 10 PCDFs, 4 co-planar PCBs, and 6 mono-ortho PCBs. The list of non-dioxin like PCBs (NDL-PCBs) included congeners 18, 28, 44, 49, 52, 66, 74, 87, 99, 101, 110, 128, 138, 146, 149, 151, 153, 170, 172, 177, 178, 180, 183, 187, 190, 194, 195, 196, 199, 203, 206, 209. Congeners are identified according to the International Union for Pure and Applied Chemistry (IUPAC) nomenclature.
Prior to analysis of study samples the laboratory carefully cleaned and checked all reagents, solvents, and glassware, and analyzed a method blank to confirm that it was free from interference. Then each set of four samples was extracted and analyzed with one method blank, which was treated identically to the serum samples.
For the analysis of dioxins, furans and co-planar PCBs the serum samples were spiked with a mixture of 13C12-labeled PCDDs/PCDFs and PCBs as internal standards. Methods for sample preparation, clean up and analysis follow US Environmental Protection Agency (EPA) methods 1613  and 1668 . Analysis was performed using a Thermo Finnigan MAT 95XP. The analytes were separated on a capillary column (SGE-BPX5, 30 meters, 0.25 mm, 0.25 microns) and quantified using selected-ion-monitoring high resolution (10,000 resolving power) mass spectrometry (HRGC-ID/HRMS). Quantification was by isotope dilution mass spectrometry using calibration standards containing 13C labeled and unlabeled analytes. Mono-ortho (M-PCBs) and non-dioxin-like PCBs were separated on a capillary column (SGE-HT8, 30 meters, 0.25 mm, 0.25 microns).
LODs were calculated as three times chromatographic noise. The LODs for dioxins and furans ranged from 0.01 to 0.04 pg/g, and for C-PCBs from 0.1 to 0.6 pg/g serum. The levels of target analytes in 4 blanks analyzed with study samples were below the LODs. The mean (SD) recoveries were 90% (5.5) for TCDD and 84% (3.1) for HxCDD.
Serum total cholesterol and triglycerides were measured with an enzymatic colorimetric assay using the COBAS INTEGRA 400 plus system, and the serum total lipid content was calculated using the Phillips equation . All PCDD/PCDF/PCB serum concentrations were lipid-adjusted. Individual congener concentrations below the limit of detection (LOD) were assigned a value equal to the LOD divided by the square root of 2 [19, 20].
The serum concentrations of PCDD/PCDF/PCBs were summarized with two measures: the total sum of toxic equivalencies (i.e. total TEQ ) for PCDDs, PCDFs, co-planar PCBs (C-PCBs) and mono-ortho PCBs (M-PCBs); and the sum of all 36 assayed non-coplanar PCB concentrations (i.e. ∑PCBs).
Pearson correlation coefficients were calculated for the log10-transformed serum concentrations in 2000 and 2009; 95% confidence intervals (CIs) for the correlation coefficients were calculated using the method of Shen and Lu .
Individual characteristics and serum concentrations of total TEQs and ∑PCBs, in 2000 and 2009, among 8 Russian women
Total TEQs (pg/g lipid)
∑ PCBs (ng/g lipid)
BMI percent change, 2000 to 2009
BMI in 2009
Months of breastfeeding, 2000 to 2009
Percent change, 2000 to 2009
Percent change, 2000 to 2009
Serum concentrations of total TEQs and ∑PCBs
The total TEQ and ∑PCB serum concentrations in both 2000 and 2009 are shown in Table 1 (results for all measured congeners are shown in Additional File 1, Table S1). The mean serum concentrations in 2000 and 2009 were, for total TEQs, 36 and 25 pg/g lipid, and for ∑PCBs, 291 and 211 ng/g lipid, respectively. Excluding the one woman who moved to Chapaevsk in 2000 (and therefore does not reflect the exposure levels of long-term residents), the respective 2000 and 2009 mean serum concentrations were, for total TEQs, 39 and 26 pg/g lipid, and for ∑PCBs, 312 and 210 ng/g lipid.
Several individual characteristics were associated with the magnitude of the changes in serum concentration between 2000 and 2009 (although the small sample size precluded formal statistical analyses on these predictors). First, a greater decrease in both total TEQs and ∑PCBs was observed among the four women with the largest increases in BMI during this nine year period, as compared to the other four women. TEQs decreased by an average of 39% among women whose BMIs increased by 10% or more, compared to 22% among women whose BMIs increased <10% or decreased. Similarly, PCBs decreased by an average of 42% among the former group of women, but increased by 3.8% among the latter. The latter group also includes the only woman's whose BMI was >30 kg/m2 at either assessment. Second, the four women who breastfed longest (i.e. ≥12 months) had larger average decreases in TEQs than the women who breastfed less (-37% vs. -23% for TEQs, respectively), but there was not a greater decrease in PCBs by breastfeeding duration (-20% vs -19%, respectively).
Correlations between serum concentrations in 2000 and 2009
The Pearson correlations between the log10-transformed serum concentrations in 2000 and 2009 were 0.3 (95% CI: -0.5; 0.8) for total TEQs (after excluding the highest value, which had inflated the correlation to 0.8), and 0.1 (95% CI: -0.6; 0.7) for ∑PCBs. However, the interpretability of these correlations was limited by the extremely wide confidence intervals.
This study consisted of eight women from a town in Russia with high exposure to dioxins and PCBs from non-occupational sources. Each woman's serum concentration of dioxins and PCBs was assessed in both 2000 and 2009. All of the women's serum concentrations of both total TEQs and ∑PCBs were greater than the 90th percentile values for US women 20 to 39 years of age in 2003-2004 (i.e. 16.2 pg/g lipid for total TEQs, and 157.8 ng/g lipid for ∑PCBs ) For almost all of the women, serum concentrations of total TEQs and ∑PCBs decreased substantially between 2000 and 2009 and, as expected, larger decreases were seen among women with greater BMI increases .
Although one must exercise caution in making inferences to the entire population of Chapaevsk (pop. 72,000) from the decreases observed among these eight women, concordant results were seen in our recent cross-sectional study among Chapaevsk women . 446 adult women's serum concentrations of PCDD/PCDF/PCBs were collected between 2003 and 2005, with average serum concentrations similar to those seen here. Levels were lower among women sampled later in the study period, adjusting for all other predictors. In multivariate linear regressions a one-year later blood draw was associated with 9.8% lower mean serum concentrations of ∑PCBs, and 10.5% lower mean total TEQs. While these age-adjusted regression results should not be interpreted as predictive of longitudinal changes in serum concentrations, they do suggest a trend similar to what was observed among the eight women.
Strengths and limitations
This study is one of the few to measure repeated serum concentrations of PCDD/PCDF/PCBs in a non-occupationally and non-accidentally exposed cohort. A particular strength of this study is that serum samples from both 2000 and 2009 were analyzed at the same time, precluding any potential bias from laboratory drift. Dioxins and PCBs are highly stable in stored serum , thus little degradation would be expected in the samples stored since 2000. However, the small sample size of eight women warrants that these findings be interpreted with caution. Furthermore, no longitudinal data on consumption of local meat or produce was available to assess the contribution of changing dietary patterns to the temporal changes in TEQ and PCB serum concentrations observed here.
This study reports the serum dioxin and PCB concentrations of adult women from a Russian town with high levels of non-occupational exposure to these compounds. All the women's levels were higher than typically seen in the US. Each woman was sampled twice: in 2000 and again in 2009. Among most of the women, serum concentrations of dioxins and PCBs decreased over this time period. Decreases were seen for all classes of dioxin-like compounds (i.e. PCDDs, PCDFs, C-PCBs and M-PCBs).
These results, while based on a small number of women, are consistent with those from our large cross-sectional study recently conducted among women in the same town. In the latter study, serum concentrations of dioxins and PCBs were lower, on average, among women sampled later in the study period, adjusting for all other predictors. While it is known that a general trend towards decreasing dioxin and PCB levels exists in the general population [25, 26], it is significant that this also appears to be true among women living in an environment with a substantial, and relatively recent (SVZH ceased operations in 2003, although production started decreasing in 1991), non-occupational exposure source.
List of abbreviations
Body mass index kg/m2
limit of detection
nanogram per gram, 10-9 g
picogram per gram, 10-12 g
Middle Volga Chemical Plant
World Health Organization
We gratefully thank the study participants, and the staff of the Chapaevsk Medical Association. The research described in this article has been reviewed by the National Institute of Environmental Health Sciences, and approved for publication. Approval does not signify that the contents necessarily reflect the views of the Agency, nor does the mention of trade names or commercial products constitute endorsement or recommendation for use. This work was funded by U.S. EPA grant R82943701 and NIEHS grants ES014370, ES00002, and 5T32-ES07069-28. OH was supported by 5T32ES016645-02 from NIEHS/NHGRI. MML is a member of the UMass DERC (DK32520). LA is a consultant for Environmental Health and Engineering, Inc. CE is an International Consultant and the President of BioSimulation Consulting Inc.
- ATSDR: Toxicological Profile for Polychlorinated Biphenyls (PCBs). 2000, Atlanta, GA
- Schecter A, Birnbaum L, Ryan JJ, Constable JD: Dioxins: an overview. Environ Res. 2006, 101: 419-428. 10.1016/j.envres.2005.12.003.View Article
- Milbrath MO, Wenger Y, Chang CW, Emond C, Garabrant D, Gillespie BW, Jolliet O: Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect. 2009, 117: 417-425.View Article
- Duarte-Davidson R, Jones KC: Polychlorinated biphenyls (PCBs) in the UK population: estimated intake, exposure and body burden. Sci Total Environ. 1994, 151: 131-152. 10.1016/0048-9697(94)90170-8.View Article
- Hansen L, DeCaprio A, Nisbet I: PCB congener comparisons reveal exposure histories for residents of Anniston, Alabama, USA. Fresenius Environmental Bulletin. 2003, 12: 181-190.
- Kocan A, Petrik J, Jursa S, Chovancova J, Drobna B: Environmental contamination with polychlorinated biphenyls in the area of their former manufacture in Slovakia. Chemosphere. 2001, 43: 595-600. 10.1016/S0045-6535(00)00411-2.View Article
- Revich B, Aksel E, Ushakova T, Ivanova I, Zhuchenko N, Klyuev N, Brodsky B, Sotskov Y: Dioxin exposure and public health in Chapaevsk, Russia. Chemosphere. 2001, 43: 951-966. 10.1016/S0045-6535(00)00456-2.View Article
- Zheng GJ, Leung AO, Jiao LP, Wong MH: Polychlorinated dibenzo-p-dioxins and dibenzofurans pollution in China: sources, environmental levels and potential human health impacts. Environ Int. 2008, 34: 1050-1061. 10.1016/j.envint.2008.02.011.View Article
- Patterson DG, Turner WE, Caudill SP, Needham LL: Total TEQ reference range (PCDDs, PCDFs, cPCBs, mono-PCBs) for the US population 2001-2002. Chemosphere. 2008, 73: S261-277. 10.1016/j.chemosphere.2007.08.074.View Article
- Patterson DG, Wong LY, Turner WE, Caudill SP, Dipietro ES, McClure PC, Cash TP, Osterloh JD, Pirkle JL, Sampson EJ, Needham LL: Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements. Environ Sci Technol. 2009, 43: 1211-1218. 10.1021/es801966w.View Article
- Furst P: Dioxins, polychlorinated biphenyls and other organohalogen compounds in human milk. Levels, correlations, trends and exposure through breastfeeding. Mol Nutr Food Res. 2006, 50: 922-933. 10.1002/mnfr.200600008.View Article
- Burns JS, Williams PL, Sergeyev O, Korrick S, Lee MM, Revich B, Altshul L, Patterson DG, Turner WE, Needham LL, Saharov I, Hauser R: Predictors of serum dioxins and PCBs among peripubertal Russian boys. Environ Health Perspect. 2009, 117: 1593-1599.View Article
- Humblet O, Williams PL, Korrick SA, Sergeyev O, Emond C, Birnbaum LS, Burns JS, Altshul L, Patterson DG, Turner WE, Lee MM, Revich B, Hauser R: Predictors of serum dioxin, furan, and PCB concentrations among women from Chapaevsk, Russia. Environ Sci Technol. 2010, 44: 5633-5640. 10.1021/es100976j.View Article
- Sergeyev O, Saharov I, Shelepchikov AA, Revich B, Sotskov Y, Brodsky E, Denisova T, Feshin D, Zeilert V: Levels of PCDDs/PCDFs in the environment and food after 3 years of full plant inactivity, Chapaevsk, Russia. Organohalogen Compounds. 2007, 69: 1388-1391.
- Hauser R, Williams P, Altshul L, Korrick S, Peeples L, Patterson DG, Turner WE, Lee MM, Revich B, Sergeyev O: Predictors of serum dioxin levels among adolescent boys in Chapaevsk, Russia: a cross-sectional pilot study. Environ Health. 2005, 4: 8-10.1186/1476-069X-4-8.View Article
- US Environmental Protection Agency Method 1613: Tetra- through Octa-Chlorinated Dioxins and Furans by Isotope Dilution HRGC/HRMS. [http://www.epa.gov/region03/1613.pdf]
- US Environmental Protection Agency Method 1668B: Chlorinated Biphenyl Congeners in Water, Soil, Sediment, Biosolids, and Tissue by HRGC/HRMS. [http://water.epa.gov/scitech/methods/cwa/bioindicators/upload/2009_01_07_methods_method_1668.pdf]
- Phillips DL, Pirkle JL, Burse VW, Bernert JT, Henderson LO, Needham LL: Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol. 1989, 18: 495-500. 10.1007/BF01055015.View Article
- Baccarelli A, Pfeiffer R, Consonni D, Pesatori AC, Bonzini M, Patterson DG, Bertazzi PA, Landi MT: Handling of dioxin measurement data in the presence of non-detectable values: overview of available methods and their application in the Seveso chloracne study. Chemosphere. 2005, 60: 898-906. 10.1016/j.chemosphere.2005.01.055.View Article
- Hornung RW, Reed LD: Estimation of average concentration in the presence of non-detectable values. Applied Occupational Environmental Hygiene. 1990, 5: 48-51.View Article
- Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws L, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walker N, Peterson RE: The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci. 2006, 93: 223-241. 10.1093/toxsci/kfl055.View Article
- Computation of Correlation Coefficient and Its Confidence Interval in SAS. Paper 170-31. [http://www2.sas.com/proceedings/sugi31/170-31.pdf]
- Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD: Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2224-2236. 10.1158/1055-9965.EPI-05-0173.View Article
- NIOSH Manual of Analytical Methods, POLYCHLORINATED BIPHENYLS in serum: METHOD 8004. [http://www.cdc.gov/niosh/docs/2003-154/pdfs/8004.pdf]
- Lorber M: A pharmacokinetic model for estimating exposure of Americans to dioxin-like compounds in the past, present, and future. Sci Total Environ. 2002, 288: 81-95. 10.1016/S0048-9697(01)01119-6.View Article
- Lorber M, Patterson D, Huwe J, Kahn H: Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s. Chemosphere. 2009, 77: 640-651. 10.1016/j.chemosphere.2009.08.016.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.